Evidence map›Paper›PMID 26201295›Full record

ArticleScientific reports2015

Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway.

Jiehui Di, Hui Huang, Debao Qu, Juangjuan Tang, Wenjia Cao, Zheng Lu, Qian Cheng, Jing Yang, Jin Bai, Yanping Zhang and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. TGF-β1-induced RAP2 regulates invasion in pancreatic cancer.Acta biochimica et biophysica Sinica · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jiehui Di1] Cancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China [2] Department of Radiation Oncology and Lineberger Comprehensive Cancer Center, School of Medicine, the University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27514, USA.
Hui Huang1] Cancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China [2] Department of Oncology, the People's Hospital of Kaixian, Kaixian 405400, Chongqing, P.R. China.
Debao QuCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Juangjuan TangCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Wenjia CaoCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Zheng LuCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Qian ChengCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Jing YangCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Jin BaiCancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.
Yanping Zhang1] Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China [2] Department of Radiation Oncology and Lineberger Comprehensive Cancer Center, School of Medicine, the University of North Carolina at Chapel Hill, 101 Manning Drive, Chapel Hill, NC 27514, USA.
Junnian ZhengJiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical College, Xuzhou 221002, Jiangsu, P.R. China.

Funding

Regulation of MDM2 by the ribosomal protein L11R01CA100302 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, YANPING · 2003 to 2013
$3.2M
Mitochondrial p32 regulation of the Mdm2-p53 tumor suppression signaling and apopR01CA155235 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, YANPING · 2012 to 2016
$1.5M
In vivo function of Mdm2 E3 ubiquitin ligaseR01CA127770 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, YANPING · 2008 to 2013
$1.5M
NCI NIH HHS R01 CA100302NCI NIH HHS R01 CA127770NCI NIH HHS R01 CA155235
6 · The paper itself

Abstract

Rap2B, a member of GTP-binding proteins, is widely upregulated in many types of tumors and promotes migration and invasion of human suprarenal epithelioma. However, the function of Rap2B in breast cancer is unknown. Expression of Rap2B was examined in breast cancer cell lines and human normal breast cell line using Western blot analysis. Using the CCK-8 cell proliferation assay, cell cycle analysis, and transwell migration assay, we also elucidated the role of Rap2B in breast cancer cell proliferation, migration, and invasion. Results showed that the expression of Rap2B is higher in tumor cells than in normal cells. Flow cytometry and Western blot analysis revealed that Rap2B elevates the intracellular calcium level and further promotes extracellular signal-related kinase (ERK) 1/2 phosphorylation. By contrast, calcium chelator BAPTM/AM and MEK inhibitor (U0126) can reverse Rap2B-induced ERK1/2 phosphorylation. Furthermore, Rap2B knockdown inhibits cell proliferation, migration, and invasion abilities via calcium related-ERK1/2 signaling. In addition, overexpression of Rap2B promotes cell proliferation, migration and invasion abilities, which could be neutralized by BAPTM/AM and U0126. Taken together, these findings shed light on Rap2B as a therapeutic target for breast cancer.

Indexed as

Calcium SignalingMAP Kinase Signaling SystemBreast NeoplasmsCalciumCell Line, TumorCell MovementCell ProliferationHumansNeoplasm Invasivenessrap GTP-Binding ProteinsCalciumRAP2B protein, humanrap GTP-Binding Proteins

Identifiers

PMID26201295
PMCPMC4512009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.